BlackRock Japan’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$67K Sell
2,760
-491
-15% -$11.3K ﹤0.01% 931
2016
Q3
$82K Sell
3,251
-198
-6% -$4.74K ﹤0.01% 913
2016
Q2
$71K Hold
3,449
﹤0.01% 942
2016
Q1
$69K Buy
3,449
+78
+2% +$1.5K ﹤0.01% 969
2015
Q4
$68K Buy
3,371
+975
+41% +$20.5K ﹤0.01% 980
2015
Q3
$56K Sell
2,396
-225
-9% -$5.74K ﹤0.01% 955
2015
Q2
$67K Sell
2,621
-11
-0.4% -$312 ﹤0.01% 1022
2015
Q1
$87K Sell
2,632
-12,926
-83% -$419K ﹤0.01% 975
2014
Q4
$472K Buy
15,558
+12,544
+416% +$346K ﹤0.01% 763
2014
Q3
$73K Sell
3,014
-251
-8% -$6.96K ﹤0.01% 998
2014
Q2
$94K Sell
3,265
-2,398
-42% -$69.7K ﹤0.01% 942
2014
Q1
$158K Sell
5,663
-4,512
-44% -$124K ﹤0.01% 982
2013
Q4
$266K Buy
10,175
+4,662
+85% +$120K ﹤0.01% 866
2013
Q3
$127K Sell
5,513
-886
-14% -$21.8K ﹤0.01% 970
2013
Q2
$167K Buy
+6,399
New +$185K ﹤0.01% 895

Other funds holding SBRA

BlackRock Japan's SBRA Position: Q4 2016 in Review

BlackRock Japan reduced its Sabra Healthcare REIT (SBRA) stake by 15% in Q4 2016, selling an estimated $11.3K and leaving 2,760 shares worth $67K. The position accounts for ﹤0.01% of the portfolio, ranked #931.

BlackRock Japan first reported a position in SBRA in Q2 2013 and has held it in 15 quarters since. The position peaked at $472K in Q4 2014. 197 funds tracked by Wall St. Rank hold SBRA as of Q4 2016.

  • BlackRock Japan held 2,760 shares of Sabra Healthcare REIT worth $67K as of Q4 2016.
  • BlackRock Japan sold 491 Sabra Healthcare REIT shares in Q4 2016, an estimated $11.3K.
  • Sabra Healthcare REIT made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #931 holding.
  • BlackRock Japan first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Japan's Sabra Healthcare REIT position peaked at $472K in Q4 2014.
  • 197 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.